Owen Male | Senior Associate
CRA, Charles River Associates
Strategy Consultant specializing in pharmaceutical and biotech industries.
Manage and lead project engagements focusing on determining the commercial potential of new therapies and helping clients develop strategies for drug development, pricing, market access and reimbursement, and commercialization.
Experience across a number of therapeutic areas and healthcare markets with a particular interest in rare diseases and oncology, regularly writing insights articles on both and co-leading CRA's internal Rare Disease Thought Leadership platform.
Appearances:
Day 2 - Thursday 24 October @ 14:10
Maximizing Value & Positioning in the Emerging Competitive Rare Disease Arena
With increasing numbers of rare diseases served by multiple approved therapies, we are seeing the return on investment for Orphan Drug incentives and the emergence of competitive arenas. Given the unique challenges in rare diseases, how could policies evolve and where should industry focus their efforts to meet payer evidence expectations and effectively position in the evolving environment?
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events